Clinical Research Unit, Division of Cardiothoracic Surgery, Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
Ann Thorac Surg. 2013 Dec;96(6):2135-41. doi: 10.1016/j.athoracsur.2013.06.085. Epub 2013 Sep 7.
The optimal method of arterial cannulation and circulation management for acute type A aortic dissection (type A) remains debated. Moderate hypothermic circulatory arrest (MHCA) and unilateral selective antegrade cerebral perfusion (uSACP) is effective in the elective setting. In this study, the impact of MHCA and uSACP on outcomes for type A repair was evaluated.
A retrospective review identified 346 patients who underwent type A repair under circulatory arrest, including 193 patients who had MHCA/uSACP. Measured outcomes included operative mortality, permanent neurologic deficit (PND) and temporary neurologic deficit, renal failure, and tracheostomy. Propensity-adjusted, multivariable logistic regression analysis was used to model adverse outcomes.
The mean age of MHCA/uSACP patients was 56 years. The mean temperature during MHCA was 26.9 ± 2.0°C. Operative mortality for MHCA/SACP patients was 9.8% compared with 20.3% for the non-MHCA/SACP group (p < 0.01). Propensity score analysis found that MHCA/uSACP did not represent an adverse risk factor for mortality, temporary neurologic deficit, PND, renal failure, or the need for tracheostomy compared with non-MHCA/uSACP techniques. There was a 2.32-fold higher incidence of PND among patients who underwent cross-clamping of the dissected aorta during cooling before circulatory arrest (p < 0.05).
Emergent type A repair can be accomplished with respectable operative risk using MHCA/uSACP. Cross-clamping the dissected aorta before MHCA increases the incidence of PND. These data suggest that MHCA/uSACP represents an effective circulation management strategy for patients undergoing repair of type A and obviates the need for deep hypothermic circulatory arrest.
急性 A 型主动脉夹层(A 型)的最佳动脉插管和循环管理方法仍存在争议。中度低温循环停止(MHCA)和单侧选择性顺行脑灌注(uSACP)在择期情况下是有效的。在这项研究中,评估了 MHCA 和 uSACP 对 A 型修复结果的影响。
回顾性分析确定了 346 例在循环停止下接受 A 型修复的患者,其中 193 例患者接受 MHCA/uSACP。测量的结果包括手术死亡率、永久性神经功能缺损(PND)和暂时性神经功能缺损、肾衰竭和气管造口术。采用倾向调整的多变量逻辑回归分析来模拟不良结局。
MHCA/uSACP 患者的平均年龄为 56 岁。MHCA 期间的平均温度为 26.9±2.0°C。MHCA/SACP 患者的手术死亡率为 9.8%,而非 MHCA/SACP 组为 20.3%(p<0.01)。倾向评分分析发现,与非 MHCA/uSACP 技术相比,MHCA/uSACP 并不是导致死亡率、暂时性神经功能缺损、PND、肾衰竭或需要气管造口术的不利危险因素。在循环停止前冷却时对夹层主动脉进行交叉钳夹的患者中,PND 的发生率高出 2.32 倍(p<0.05)。
使用 MHCA/uSACP 可以完成具有可观手术风险的紧急 A 型修复。在 MHCA 前对夹层主动脉进行交叉钳夹会增加 PND 的发生率。这些数据表明,MHCA/uSACP 代表了一种有效的循环管理策略,适用于接受 A 型修复的患者,并避免了深低温循环停止的需要。